These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22400112)

  • 1. Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours.
    Trojan J; Pan YX; Wei MX; Ly A; Shevelev A; Bierwagen M; Ardourel MY; Trojan LA; Alvarez A; Andres C; Noguera MC; Briceno I; Aristizabal BH; Kasprzak H; Duc HT; Anthony DD
    Chemother Res Pract; 2012; 2012():721873. PubMed ID: 22400112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I triple helix gene therapy of rat and human gliomas.
    Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
    Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
    Ly A; Duc HT; Kalamarides M; Trojan LA; Pan Y; Shevelev A; François JC; Noël T; Kane A; Henin D; Anthony DD; Trojan J
    Mol Pathol; 2001 Aug; 54(4):230-9. PubMed ID: 11477137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis.
    Ly A; Francois JC; Upegui-Gonzalez LC; Swiercz B; Bedel C; Duc HT; Bout D; Trojan J
    Life Sci; 2000 Dec; 68(3):307-19. PubMed ID: 11191646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma.
    Trojan A; Lone YC; Briceno I; Trojan J
    Curr Med Chem; 2024; 31(15):1983-2002. PubMed ID: 38031775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense anti IGF-I cellular therapy of malignant tumours: immune response in cancer patients.
    Trojan J; Ly A; Wei MX; Bierwagen M; Kopinski P; Pan Y; Ardourel MY; Dufour T; Shevelev A; Trojan LA; François JC; Andres C; Popiela T; Chatel M; Kasprzak H; Anthony DD; Duc HT
    Biomed Pharmacother; 2010 Oct; 64(8):576-8. PubMed ID: 20630696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I triple helix strategy in hepatoma treatment.
    Upegui-Gonzalez LC; Ly A; Sierzega M; Jarocki P; Trojan L; Duc HT; Pan Y; Shevelev A; Henin D; Anthony D; Nowak W; Popiela T; Trojan J
    Hepatogastroenterology; 2001; 48(39):660-6. PubMed ID: 11462897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.
    Trojan LA; Kopinski P; Wei MX; Ly A; Glogowska A; Czarny J; Shevelev A; Przewlocki R; Henin D; Trojan J
    Acta Biochim Pol; 2002; 49(4):979-90. PubMed ID: 12545204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.
    Jan CI; Tsai WC; Harn HJ; Shyu WC; Liu MC; Lu HM; Chiu SC; Cho DY
    Front Immunol; 2018; 9():727. PubMed ID: 29910795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
    Szpechcinski A; Trzos R; Jarocki P; Trojan LA; Oficjalska K; Junkiert A; Wei MX; Mazurek M; Czapiewska JL; Niklinski J; Kopiński P; Chyczewski L; Kasacka I; Trojan J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():98-104. PubMed ID: 15638388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.
    Parney IF; Petruk KC; Zhang C; Farr-Jones M; Sykes DB; Chang LJ
    Hum Gene Ther; 1997 Jun; 8(9):1073-85. PubMed ID: 9189765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
    Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
    Lee A; Arasaratnam M; Chan DLH; Khasraw M; Howell VM; Wheeler H
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013238. PubMed ID: 32395825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of the antisense and triplex anti-IGF-1 techniques for postoperative cellular gene therapy of malignant gliomas expressing IGF-1].
    Kasprzak HA; Trojan J; Bierwagen M; Kopiński P; Jarocki P; Bartczak K; Czapiewska J
    Neurol Neurochir Pol; 2006; 40(6):509-15; discussion 516. PubMed ID: 17199177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells.
    Rininsland F; Johnson TR; Chernicky CL; Schulze E; Burfeind P; Ilan J
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5854-9. PubMed ID: 9159164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas.
    Okada H; Lieberman FS; Walter KA; Lunsford LD; Kondziolka DS; Bejjani GK; Hamilton RL; Torres-Trejo A; Kalinski P; Cai Q; Mabold JL; Edington HD; Butterfield LH; Whiteside TL; Potter DM; Schold SC; Pollack IF
    J Transl Med; 2007 Dec; 5():67. PubMed ID: 18093335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
    Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
    Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.
    Trojan J; Johnson TR; Rudin SD; Ilan J; Tykocinski ML; Ilan J
    Science; 1993 Jan; 259(5091):94-7. PubMed ID: 8418502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.